Expert Interviews

Disrupting the glaucoma treatment paradigm with novel femtosecond laser from ViaLase

Shawn O'Neil of ViaLase shares updates on the company's femtosecond laser, image-guided, high-precision trabeculotomy (FLigHT) treatment.

Trukera Medical rebranding ushers in new era of expansion into cornea market

Adam Szaronos, President and CEO of Trukera Medical, discusses the recent rebranding of TearLab as well as the launch of the ScoutPro Osmolarity System.

2-year data in contralateral eye evaluation gives edge to iStent inject over Hydrus stent

At AAO 2022, Dr Mitch Shultz provides discourse on iStent inject vs Hydrus contralateral eye evaluation data.